239 related articles for article (PubMed ID: 34268631)
1. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
3. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T
J Clin Endocrinol Metab; 2008 Jun; 93(6):2115-21. PubMed ID: 18397986
[TBL] [Abstract][Full Text] [Related]
4. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
5. Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes.
Nishimura A; Nagasawa K; Okubo M; Kobayashi T; Mori Y
Endocr J; 2015; 62(12):1077-82. PubMed ID: 26440526
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström BO; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen MR; Groop LC
Diabetes; 1999 Jan; 48(1):150-7. PubMed ID: 9892237
[TBL] [Abstract][Full Text] [Related]
9. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
[TBL] [Abstract][Full Text] [Related]
10. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features.
Grasso YZ; Reddy SK; Rosenfeld CR; Hussein WI; Hoogwerf BJ; Faiman C; Gupta MK
Endocr Pract; 2001; 7(5):339-45. PubMed ID: 11585368
[TBL] [Abstract][Full Text] [Related]
12. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus.
Sugihara S; Konda S; Wataki K; Kobayashi Y; Murata A; Miyamoto S; Kubo H; Yamaguchi A; Sasaki N; Niimi H
Acta Paediatr; 1996 May; 85(5):558-63. PubMed ID: 8827099
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes.
Hamaguchi K; Kimura A; Kusuda Y; Yamashita T; Yasunami M; Takahasi M; Abe N; Yoshimatsu H
Diabetes Res Clin Pract; 2004 Nov; 66(2):163-71. PubMed ID: 15533584
[TBL] [Abstract][Full Text] [Related]
16. [Detection of LADA-type diabetes in overweight diabetic patients. Is treatment with metformin suitable?].
Lóriz Peralta O; Campos Bonilla B; Granada Ybern ML; Sanmartí Sala A; Arroyo Bros J;
Aten Primaria; 2007 Mar; 39(3):133-7. PubMed ID: 17386205
[TBL] [Abstract][Full Text] [Related]
17. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.
Juneja R; Hirsch IB; Naik RG; Brooks-Worrell BM; Greenbaum CJ; Palmer JP
Metabolism; 2001 Sep; 50(9):1008-13. PubMed ID: 11555830
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
[TBL] [Abstract][Full Text] [Related]
19. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Hawa MI; Buchan AP; Ola T; Wun CC; DeMicco DA; Bao W; Betteridge DJ; Durrington PN; Fuller JH; Neil HA; Colhoun H; Leslie RD; Hitman GA
Diabetes Care; 2014 Jun; 37(6):1643-9. PubMed ID: 24722498
[TBL] [Abstract][Full Text] [Related]
20. Latent autoimmune diabetes amongst adults with type 2 diabetes in a Nigerian tertiary hospital.
Ipadeola A; Adeleye JO; Akinlade KS
Prim Care Diabetes; 2015 Jun; 9(3):231-6. PubMed ID: 25311649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
